Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Xinjiang Turpan: First Autonomous Drone Inspection at a Substation 2024-11-28 21:05
Xinjiang Turpan: Photovoltaic Power Generation Reaches 1.575 Billion Kilowatt-Hours This Year 2024-11-28 20:58
Unveiling the ugee Fun Drawing Pad UT2&UT3: Make Fun Touchable and Believable 2024-11-28 20:03
bauma CHINA 2024: XCMG Leads Industry Development with Intelligent, Digital, and Green Solutions and Products 2024-11-28 19:18
Zoomlion Showcases Groundbreaking Machinery and Smart Solutions at bauma CHINA 2024 2024-11-28 18:38
HKBN Launches GigaFast Broadband with Wi-Fi 7 Routers Powered by TP-Link's Aginet Platform for the Ultimate Home Network Experience 2024-11-28 17:44
Bridging Borders: International Travel Agents and Lancang-Mekong Partners Gather in Chongqing 2024-11-28 17:24
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients 2024-11-28 17:22
Grow with Xiaomi: Building a Sustainable Open Ecosystem for Apps, Services and Contents 2024-11-28 17:04
Körber Delivers Advanced Warehouse Automation Solution for Iron Mountain 2024-11-28 16:59
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List 2024-11-28 16:59
DAHON Gains Traction with "D-VELO"，Leading New Trends in Green Mobility-themed CCBI 2024 2024-11-28 16:01
Xinhua Silk Road: Wuxi Economic Development Zone makes efforts to optimize business environment 2024-11-28 15:40
Xinhua Silk Road: Multiple achievements made at promotion conference held in Shanghai 2024-11-28 15:26
Shanghai honors 50 expats with Magnolia Silver Awards 2024-11-28 13:46
Shanghai honors 50 expats with Magnolia Silver Awards 2024-11-28 13:43
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List 2024-11-28 13:43
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country 2024-11-28 13:04
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List 2024-11-28 12:07
Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders 2024-11-28 11:44
1 18 19 20 21 22 1266